MiR-29a, Targeting Caveolin 2 Expression, Is Responsible for Limitation of Pancreatic Cancer Metastasis in Patients With Normal Level of Serum CA125

International Journal of Cancer - United States
doi 10.1002/ijc.31654

Related search